Study finds novel treatment targets for gout
Scientists identify a new molecular model and potential therapeutic target for gout, the most...
Read MoreSelect Page
Posted by Michael Jannicelli | Dec 13, 2022 | Uncategorized | 0 |
Scientists identify a new molecular model and potential therapeutic target for gout, the most...
Read MorePosted by Michael Jannicelli | Dec 12, 2022 | Uncategorized | 0 |
A new drug acts like a master reset switch in the intestines. The compound, called FexD, has...
Read MorePosted by Michael Jannicelli | Dec 8, 2022 | Uncategorized | 0 |
Commonly used drugs that reduce joint inflammation in patients with rheumatoid arthritis also...
Read MorePosted by Michael Jannicelli | Dec 5, 2022 | Uncategorized | 0 |
Autonomy means being in control of your own decisions. For pediatric patients living with IBD,...
Read MorePosted by Michael Jannicelli | Dec 5, 2022 | Uncategorized | 0 |
We are excited to welcome back former PAC co-chair, Dr. >” rel=”noopener”...
Read More